The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine

NCT03659383 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes

Interventions

COMBINATION_PRODUCT: Optimal hypoglycemic treatment

Sponsor

Nanjing First Hospital, Nanjing Medical University